{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T17:10:28Z","timestamp":1762189828103,"version":"build-2065373602"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["1 R36 HS025662\u201001A1"],"award-info":[{"award-number":["1 R36 HS025662\u201001A1"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 R21 AG049269\u201001","R01 AG046341\u201001A1"],"award-info":[{"award-number":["1 R21 AG049269\u201001","R01 AG046341\u201001A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["agsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>Our aim was to clarify if persons living with human immunodeficiency virus\/acquired immunodeficiency syndrome (HIV\/AIDS) have adequate economic access to antiretroviral therapy (ART) when admitted to nursing homes (NHs). Medicare Part A pays NHs a bundled skilled nursing rate that includes prescription drugs for up to 100\u2009days, after which individuals are responsible for the costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN<\/jats:title>\n                    <jats:p>A cross\u2010sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING<\/jats:title>\n                    <jats:p>NHs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS<\/jats:title>\n                    <jats:p>A total of 694 newly admitted long\u2010stay (&gt;100\u2009d) NH residents with HIV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS<\/jats:title>\n                    <jats:p>We used Minimum Dataset v.3.0, pharmacy dispensing data, NH provider surveys, and Medicare claims from 2011 to 2013. We assessed receipt of any HIV antiretrovirals or recommended combinations (ART), as defined by national care guidelines, and the source of payment. We identified predictors of antiretroviral use with risk\u2010adjusted generalized estimating equation logistic models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>All study persons living with HIV\/AIDS in NHs had prescription drug coverage through Medicare's Part D program, and ART was 100% covered. However, only 63.9% received recommended ART, and 15.2% never received any antiretrovirals during their NH stay. The strongest predictor of not receiving antiretrovirals was the first 100\u2009days of a long NH stay (odds ratio [OR] = .44; 95% confidence interval [CI] = .24\u2010.80). The strongest predictor of receiving recommended ART was health acuity (OR = 1.51; 95% CI = 1.20\u20101.88).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      People living with HIV in NHs do not always receive lifesaving ART, but the reasons are unclear and appear unrelated to economic barriers.\n                      <jats:bold>J Am Geriatr Soc 68:777\u2013782, 2020<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jgs.16288","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T05:44:39Z","timestamp":1576129479000},"page":"777-782","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Economic Barriers to Antiretroviral Therapy in Nursing Homes"],"prefix":"10.1111","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-2019","authenticated-orcid":false,"given":"Brianne L.","family":"Olivieri\u2010Mui","sequence":"first","affiliation":[{"name":"The Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife Harvard Medical School  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Koethe","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Health Systems Sciences Northeastern University  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Briesacher","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Health Systems Sciences Northeastern University  Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081355"},{"key":"e_1_2_8_3_1","unstructured":"Centers for Disease Control and Prevention. HIV among people aged 50 and over. 2016.http:\/\/www.cdc.gov\/hiv\/group\/age\/olderamericans\/index.html#footnotes. Accessed September 12 2019."},{"key":"e_1_2_8_4_1","unstructured":"SalibaD BuchannanJ. Development and validation of a revised nursing home assessment tool: MDS 3.0; 2008.http:\/\/www.polaris-group.com\/Polaris-Testing\/PressReleases\/MDS30FinalReportAppendix.pdf. Accessed May 2019."},{"key":"e_1_2_8_5_1","unstructured":"HenryJ.Medicare andHIV. Kaiser Family Foundation; 2016.https:\/\/www.kff.org\/hivaids\/fact-sheet\/medicare-and-hiv\/. Accessed September 13 2019."},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000843"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/JNC.0000000000000033"},{"volume-title":"Medicare Part D in 2016 and Trends Over Time","year":"2016","author":"Hoadley J","key":"e_1_2_8_8_1"},{"key":"e_1_2_8_9_1","unstructured":"Extra Help Basics. Medicare Interactive.https:\/\/www.medicareinteractive.org\/get-answers\/cost-saving-programs-for-people-with-medicare\/the-extra-helplow-income-subsidy-lis-program\/extra-help-basics. Accessed June 2019."},{"issue":"2","key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.32481\/djph.2019.05.012","article-title":"Access to HIV medication in the community versus a nursing home for the medicare eligible HIV population","volume":"5","author":"Olivieri\u2010Mui BL","year":"2019","journal-title":"Del J Public Health."},{"key":"e_1_2_8_11_1","unstructured":"Office of the Inspector General. Availability of Medicare Part D Drugs to Dual\u2010Eligible Nursing Home Residents (OEI\u201002\u201006\u201000190). 2008.https:\/\/oig.hhs.gov\/oei\/reports\/oei-02-06-00190.pdf. Accessed September 2019."},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03537.x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2006.01.024"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/44.1.13"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001215"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007161"},{"key":"e_1_2_8_17_1","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV\u20101\u2010Infected Adults and Adolescents; 2011.https:\/\/aidsinfo.nih.gov\/contentfiles\/AdultandAdolescentGL002111.pdf. Accessed January 2019."},{"key":"e_1_2_8_18_1","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV\u20101\u2010Infected Adults and Adolescents.; 2012.https:\/\/aidsinfo.nih.gov\/contentfiles\/adultandadolescentgl003093.pdf. Accessed January 2019."},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-245"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16155"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.469"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-017-0222-7"},{"issue":"6","key":"e_1_2_8_23_1","article-title":"Provider training and experience for people living with HIV\/AIDS","author":"Rackal J","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2017.05.006"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2006.00773.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu783"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt323"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.92.8.1257"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.W4.94"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjgs.16288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.16288","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jgs.16288","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jgs.16288","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:48:55Z","timestamp":1762188535000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/jgs.16288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1111\/jgs.16288"],"URL":"https:\/\/doi.org\/10.1111\/jgs.16288","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"type":"print","value":"0002-8614"},{"type":"electronic","value":"1532-5415"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"2019-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}